PHARMACEUTICAL COMPOSITION OF 1-(3,4-DIMETHOXYPHENYL)-4-METH YL5-ETHYL-7-METHOXY-8-HYDROXY-5 H-2,3-BENZODIAZEPINE AND USES THEREOF

Details for Australian Patent Application No. 2003293405 (hide)

Owner VELA PHARMACEUTICALS, INC.

Inventors KUCHARIK, Robert, F.; LEVENTER, Steven, M.; HARRIS, Herbrt, W.

Pub. Number AU-A-2003293405

PCT Number PCT/US2003/0386

PCT Pub. Number WO2004/050040

Priority 60/430,771 03.12.02 US

Filing date 3 December 2003

Wipo publication date 23 June 2004

Event Publications

22 April 2004 Complete Application Filed

  Priority application(s): 60/430,771 03.12.02 US

29 July 2004 Application Open to Public Inspection

  Published as AU-A-2003293405

18 August 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003293406-SYSTEM FOR CONSTRUCTING A MOBILITY MODEL FOR USE IN MOBILITY MANAGEMENT IN A WIRELESS COMUNICATION SYSTEM AND METHOD THEREOF

2003293404-COMPOUNDS RESISTANT TO METABOLIC DEACTIVATION AND METHODS OF USE